EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis

Min Dai, Yuxiong Jiang, Yujing Xi, Lezhen Xu iD, Dawei Huang iD, Yu Wang, Yifan Hu, Qian Yu, Yuling Shi iD

Psoriasis: Targets and Therapy · 2025-10 · Volume 15 · 513-525

DOI: 10.2147/ptt.s544568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psoriasis: Targets and Therapy, 2025-10. Verfasst von Min Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

clinical efficacydisease durationpatients reported outcomespsoriasissystemic therapy

Autor:innen und Institutionen

  • Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Institute of Psoriasis, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Kashi Prefecture Second People's Hospital, Kashi, Xinjiang, People's Republic of China.
  • Department of Dermatology, The Third Affliated Hospital of Naval Medical University, Shanghai, People's Republic of China.
  • Psoriasis Clinical Research Center, Tongji University, Shanghai, People's Republic of China.

ORCID-Profile: Lezhen Xu, Dawei Huang, Yuling Shi

Zitieren

APA

Dai, M., Jiang, Y., Xi, Y., Xu, L., Huang, D., Wang, Y., Hu, Y., Yu, Q., & Shi, Y. (2025). Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis. Psoriasis: Targets and Therapy, Volume 15, 513-525. https://doi.org/10.2147/ptt.s544568

Vancouver

Dai M, Jiang Y, Xi Y, Xu L, Huang D, Wang Y, et al. Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis. Psoriasis: Targets and Therapy. 2025;Volume 15:513-525. doi:10.2147/ptt.s544568

BibTeX
@article{Dai2025,
  author = {Dai, Min and Jiang, Yuxiong and Xi, Yujing and Xu, Lezhen and Huang, Dawei and Wang, Yu and Hu, Yifan and Yu, Qian and Shi, Yuling},
  title = {Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis},
  journal = {Psoriasis: Targets and Therapy},
  year = {2025},
  volume = {Volume 15},
  pages = {513--525},
  doi = {10.2147/ptt.s544568}
}
Kostenlos starten →